
Wegovy, Zepbound, and Foundayo drop to $50 a month under Medicare’s GLP-1 Bridge starting July 1 — but the copay won’t count toward the new $2,100 Part D out-of-pocket cap
Starting July 1, 2026, Medicare beneficiaries who qualify for the new GLP-1 Bridge demonstration will pay a flat $50 per month for Wegovy, Zepbound, or Foundayo. The program runs through December 31, 2027, and requires no registration or opt-in. But the $50 copay sits entirely outside the Part D benefit




